JOHN PRICE: Open Payments
NPI 1295095966 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: GVOKE HYPOPEN, AIRSUPRA, VOQUEZNA, REXULTI, Korlym, PREVNAR 20, Kerendia, CAPLYTA.
Industry payments across OH — which companies pay providers there.
